CN116355972A - Fermentation process for producing L-homoserine by recombinant escherichia coli - Google Patents
Fermentation process for producing L-homoserine by recombinant escherichia coli Download PDFInfo
- Publication number
- CN116355972A CN116355972A CN202310208931.XA CN202310208931A CN116355972A CN 116355972 A CN116355972 A CN 116355972A CN 202310208931 A CN202310208931 A CN 202310208931A CN 116355972 A CN116355972 A CN 116355972A
- Authority
- CN
- China
- Prior art keywords
- homoserine
- fermentation
- fermentation process
- producing
- recombinant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 181
- 230000004151 fermentation Effects 0.000 title claims abstract description 181
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 title claims abstract description 157
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 title claims abstract description 85
- 241000588724 Escherichia coli Species 0.000 title claims abstract description 38
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 49
- 239000008103 glucose Substances 0.000 claims abstract description 49
- 238000004519 manufacturing process Methods 0.000 claims abstract description 32
- 230000001580 bacterial effect Effects 0.000 claims abstract description 23
- 239000001963 growth medium Substances 0.000 claims description 59
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 42
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 41
- 229960004452 methionine Drugs 0.000 claims description 41
- 239000004473 Threonine Substances 0.000 claims description 40
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 39
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 39
- 235000001014 amino acid Nutrition 0.000 claims description 39
- 150000001413 amino acids Chemical class 0.000 claims description 38
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 32
- 239000004472 Lysine Substances 0.000 claims description 30
- 229930182817 methionine Natural products 0.000 claims description 29
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 28
- 235000018977 lysine Nutrition 0.000 claims description 28
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 26
- 229910052760 oxygen Inorganic materials 0.000 claims description 26
- 239000001301 oxygen Substances 0.000 claims description 26
- 229960003237 betaine Drugs 0.000 claims description 22
- 239000002904 solvent Substances 0.000 claims description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 16
- 239000012526 feed medium Substances 0.000 claims description 15
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 13
- 229940041514 candida albicans extract Drugs 0.000 claims description 13
- 239000013530 defoamer Substances 0.000 claims description 13
- 229910021645 metal ion Inorganic materials 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 239000012138 yeast extract Substances 0.000 claims description 13
- FFEARJCKVFRZRR-UHFFFAOYSA-N L-Methionine Natural products CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 claims description 12
- 229930195722 L-methionine Natural products 0.000 claims description 12
- 235000019766 L-Lysine Nutrition 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims 1
- 230000012010 growth Effects 0.000 abstract description 25
- 241001052560 Thallis Species 0.000 abstract description 8
- 239000007788 liquid Substances 0.000 description 102
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 44
- 238000011218 seed culture Methods 0.000 description 44
- 239000000203 mixture Substances 0.000 description 38
- 229960002898 threonine Drugs 0.000 description 37
- 229940024606 amino acid Drugs 0.000 description 36
- 238000011081 inoculation Methods 0.000 description 33
- 238000001514 detection method Methods 0.000 description 28
- 238000011068 loading method Methods 0.000 description 25
- 238000012360 testing method Methods 0.000 description 25
- 239000001888 Peptone Substances 0.000 description 22
- 108010080698 Peptones Proteins 0.000 description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 22
- 235000019319 peptone Nutrition 0.000 description 22
- 239000000843 powder Substances 0.000 description 22
- 239000011780 sodium chloride Substances 0.000 description 22
- 239000000243 solution Substances 0.000 description 19
- 241000894006 Bacteria Species 0.000 description 16
- 239000002609 medium Substances 0.000 description 13
- 238000005070 sampling Methods 0.000 description 13
- 238000005273 aeration Methods 0.000 description 11
- 230000008859 change Effects 0.000 description 11
- 238000012258 culturing Methods 0.000 description 11
- 238000010353 genetic engineering Methods 0.000 description 11
- 239000002054 inoculum Substances 0.000 description 11
- 230000006229 amino acid addition Effects 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 238000009630 liquid culture Methods 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- 238000005457 optimization Methods 0.000 description 9
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 230000019522 cellular metabolic process Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- LWFUFLREGJMOIZ-UHFFFAOYSA-N 3,5-dinitrosalicylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1O LWFUFLREGJMOIZ-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000020776 essential amino acid Nutrition 0.000 description 6
- 239000003797 essential amino acid Substances 0.000 description 6
- 230000004060 metabolic process Effects 0.000 description 6
- 230000037361 pathway Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- YEJRWHAVMIAJKC-UHFFFAOYSA-N 4-Butyrolactone Chemical compound O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 4
- -1 L-homoserine amino acid Chemical class 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 230000002503 metabolic effect Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000008170 thiamine pyrophosphate Nutrition 0.000 description 4
- 239000011678 thiamine pyrophosphate Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002028 Biomass Substances 0.000 description 3
- 102000012751 Pyruvate Dehydrogenase Complex Human genes 0.000 description 3
- 108010090051 Pyruvate Dehydrogenase Complex Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 102000014701 Transketolase Human genes 0.000 description 3
- 108010043652 Transketolase Proteins 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 3
- AYEKOFBPNLCAJY-UHFFFAOYSA-O thiamine pyrophosphate Chemical compound CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N AYEKOFBPNLCAJY-UHFFFAOYSA-O 0.000 description 3
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- 230000037353 metabolic pathway Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000003204 osmotic effect Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 235000019157 thiamine Nutrition 0.000 description 2
- 239000011721 thiamine Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 2
- JJGWJTGPVFFTFU-UHFFFAOYSA-N 2-chloro-1,3-dinitro-4-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC=C(C(F)(F)F)C([N+]([O-])=O)=C1Cl JJGWJTGPVFFTFU-UHFFFAOYSA-N 0.000 description 1
- JFTUSFFYSRNFBA-UHFFFAOYSA-N 3-amino-5-nitrosalicylic acid Chemical compound NC1=CC([N+]([O-])=O)=CC(C(O)=O)=C1O JFTUSFFYSRNFBA-UHFFFAOYSA-N 0.000 description 1
- 108020004306 Alpha-ketoglutarate dehydrogenase Proteins 0.000 description 1
- 102000006589 Alpha-ketoglutarate dehydrogenase Human genes 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 101100322888 Escherichia coli (strain K12) metL gene Proteins 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- QJPWUUJVYOJNMH-VKHMYHEASA-N L-homoserine lactone Chemical compound N[C@H]1CCOC1=O QJPWUUJVYOJNMH-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- 102000019010 Methylmalonyl-CoA Mutase Human genes 0.000 description 1
- 108010051862 Methylmalonyl-CoA mutase Proteins 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- FCXZBWSIAGGPCB-YFKPBYRVSA-N O-acetyl-L-homoserine Chemical compound CC(=O)OCC[C@H]([NH3+])C([O-])=O FCXZBWSIAGGPCB-YFKPBYRVSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940101006 anhydrous sodium sulfite Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229910021538 borax Inorganic materials 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229930188620 butyrolactone Natural products 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000006652 catabolic pathway Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000007872 degassing Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004110 gluconeogenesis Effects 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 101150033534 lysA gene Proteins 0.000 description 1
- 229960003646 lysine Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 101150060102 metA gene Proteins 0.000 description 1
- 101150086633 metAA gene Proteins 0.000 description 1
- 101150091110 metAS gene Proteins 0.000 description 1
- 101150043924 metXA gene Proteins 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- MZFOKIKEPGUZEN-FBMOWMAESA-N methylmalonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C(C(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MZFOKIKEPGUZEN-FBMOWMAESA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- KHPXUQMNIQBQEV-UHFFFAOYSA-N oxaloacetic acid Chemical compound OC(=O)CC(=O)C(O)=O KHPXUQMNIQBQEV-UHFFFAOYSA-N 0.000 description 1
- 229940063746 oxygen 20 % Drugs 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- VZOPRCCTKLAGPN-ZFJVMAEJSA-L potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate;tetrahydrate Chemical compound O.O.O.O.[Na+].[K+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O VZOPRCCTKLAGPN-ZFJVMAEJSA-L 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 1
- 239000004328 sodium tetraborate Substances 0.000 description 1
- 235000010339 sodium tetraborate Nutrition 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 230000037351 starvation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 229960002363 thiamine pyrophosphate Drugs 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 101150072448 thrB gene Proteins 0.000 description 1
- 101150000850 thrC gene Proteins 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention relates to the technical field of biological fermentation, and discloses a fermentation process for producing L-homoserine by recombinant escherichia coli. The fermentation process for producing L-homoserine by using the recombinant escherichia coli mainly aims at solving the problems that in the existing fermentation process for producing L-homoserine by using the recombinant escherichia coli, the growth of thalli is difficult to control and the high yield is difficult to reproduce. The invention is realized by the pH, temperature, glucose content and OD in the fermentation process 600 The value and DO value are controlled in a certain range, so that the optimal production state can be kept at each stage of the bacterial growth finally, the bacterial growth control in the fermentation process is realized, the yield of L-homoserine is finally improved, and the high yield reproducibility is good.
Description
Technical Field
The invention relates to the technical field of biological fermentation, in particular to a fermentation process for producing L-homoserine by recombinant escherichia coli.
Background
L-Homoserine (HS), an unnatural amino acid belonging to the L-aspartic acid family, is a precursor for synthesizing the essential amino acids L-threonine, L-methionine and L-isoleucine. L-homoserine is also used as an important platform compound for the synthesis of high value-added compounds such as O-acetylhomoserine, homoserine lactone, isobutanol and gamma-butyrolactone. L-homoserine also has the functions of improving plant stress resistance and promoting poultry growth. Thus, L-homoserine is expected to be widely used in the fields of foods, medical treatment, agriculture and the like.
At present, the main production mode of L-homoserine is chemical synthesis, including methionine method and butyrolactone method, but the development of the L-homoserine is limited by the factors of high price of reagents used in the reaction process, long reaction time or complicated purification steps, etc. The biological method has the advantages of green and high efficiency, low cost and easy obtainment of the substrate and the like, and is concerned by people.
In 2016, university of Jiangnan Li Hua and the like, lysA, thrB, thrC and metA genes on a competitive metabolic branch and a degradation path of escherichia coli W3110L-homoserine are knocked out, and the metL genes in the metabolic path are overexpressed through a plasmid pBR322, and meanwhile, a transportation system of the L-homoserine is further modified, and finally, the L-homoserine is fermented in a 15L fermentation tank to obtain 39.54 g/L-homoserine; in 2019, the Wei Toshiba team at the university of Huadong would also obtain homoserine high-yield strain IJL by knocking out the competition and degradation pathways and combining with the modification of the central metabolic pathway, and the fed-batch fermentation yield reaches 35.8g/L; in 2021, beijing institute of microorganisms adopted a manner of controlling the balance of reducing power to realize 84.1g/L homoserine production in the production strain with released competing and degrading pathways; the applicant's prior patent CN109055290B also provides a recombinant escherichia coli with high L-homoserine production. The recombinant E.coli producing L-homoserine as described above all suffer from the common problem that Chaetomium always suffers from the essential amino acid deficiency. The defect of essential amino acid of the strain can cause the problems of complex control process control and poor production reproducibility in the tank.
Although the transformation of the homoserine chassis realizes the high yield of homoserine to a certain extent, the industrial application standard is not yet met, and the problem of the fermentation process needs to be further solved. Therefore, aiming at the problem of knocking out the essential amino acid biosynthesis pathway of the homoserine chassis bacteria, developing a fermentation process capable of shortening the fermentation period, optimizing the growth performance and improving the fermentation yield is a problem which needs to be solved by the person skilled in the art.
Disclosure of Invention
The homoserine chassis cell knocks out the essential amino acid biosynthesis gene, and the problem that the production and growth of thalli are difficult to control in the fermentation process exists. Meanwhile, the influence caused by knocking out the essential amino acid biosynthesis genes is solved by adding defective amino acids into the culture medium, but the problem of insufficient amino acid supply in the defect of the growth process still exists, and the bacterial growth in the fermentation process is influenced, so that the yield is influenced.
In view of the above, the invention provides a fermentation process for producing L-homoserine by recombinant escherichia coli. The invention aims to improve the homoserine production fermentation method of the amino acid defective strain through fermentation process optimization, improve biomass and yield, and shorten the fermentation regulation process of the fermentation period.
The specific technical scheme of the invention is as follows:
the invention provides a fermentation process for producing L-homoserine by using recombinant escherichia coli, wherein the recombinant escherichia coli for producing the L-homoserine is used as a production strain for fermentation culture, and the fermentation process is controlled by the following parameters:
(1) pH and temperature: the pH is maintained between 6.6 and 7.0, and the temperature is maintained between 30 and 32 ℃.
(2) Glucose content: the content of glucose is 0.1-5 g/L.
(3)OD 600 Value: the bacterial cells enter a stagnation period, pulse type quantitative amino acid feeding is carried out, and OD is carried out 600 The value is in the range of 30 to 50.
(4) DO value: the DO value of the system is reduced to 9-12% for the first time, and the DO value is maintained at 9-12% after that.
Unlike available fermentation process for producing L-homoserine with recombinant colibacillus, the present invention provides one fermentation process for producing L-homoserine with recombinant colibacillus, which aims at solving the problems of hard control of thallus growth and high yield. The invention is realized by the pH, temperature, glucose content and OD in the fermentation process 600 The value and DO value are controlled in a certain range, so that the optimal production state can be kept at each stage of the bacterial growth finally, the bacterial growth control in the fermentation process is realized, and the yield of L-homoserine is finally improved. The fermentation process provided by the invention can obtain L-homoserine with the yield of 75g/L in the fermentation process within 70h, and the high yield has good reproducibility.
In the fermentation process provided by the invention, the pH and the temperature are controlled (1), the glucose content is controlled (2), and the OD is controlled (3) 600 The four aspects of (4) controlling DO value can keep the best production state of each stage of the bacterial growth, thereby achieving the reproduction of high yield. If either aspect is not met, the yield may be compromised. Specifically:
in the aspect (1), the change of the pH is the comprehensive reflection of the metabolic activity of the thalli in the fermentation process, when the pH exceeds a certain range, the thalli can lose the adjusting capability, the pH of the fermentation liquor can continuously fluctuate after losing self-adjustment, and the fluctuation of the pH of the fermentation liquor can adversely affect the thalli and the pH adjusting capability thereof. The cause of the pH fluctuation depends on the metabolism of the cells themselves, but also on the surrounding environment such as the medium. In the fermentation system for producing L-homoserine by recombinant escherichia coli, the thallus and the culture environment are integrated, and the pH is maintained at 6.6-7.0, so that the thallus is in the best production state. The temperature of 30-32 ℃ can optimize the bacterial production under the environment with pH of 6.6-7.0.
In the aspect (2), the concentration of glucose is controlled to be 0.1-5 g/L, so that the concentration of glucose is uniform in the whole fermentation process, the glucose is favorable for improving the yield of the growth metabolism of thalli, and the concentration of glucose depends on the pH and the temperature range in the aspect (1). If a large amount of glucose is fed at one time, the cells grow at a larger growth speed in the initial stage of production, and the final cell density is too high, so that the growth and metabolism of the cells are not facilitated, and meanwhile, the glucose content in the later stage is low, the requirement of the growth and metabolism of the cells cannot be met, and the yield is low.
In the aspect (3), the OD of the system is controlled by pulse-type quantitative amino acid feeding 600 The value is in the range of 30-50, so that the carbon flux can flow to the cell metabolism more, the high-yield L-homoserine is fermented, and meanwhile, in the range, the fermentation rheological property is good. If the amino acid concentration is too high, carbon flux flows to cell growth, carbon flux flowing to cell metabolism is reduced, and L-homoserine yield is reduced; in addition to the reduced flux of carbon to cellular metabolism, and the resulting excessive cell density, further impedes cellular metabolism. If the amino acid concentration is too low, the amino acid deficiency is unfavorable for the growth and metabolism of the bacterial strain because the bacterial strain is deficient in amino acid.
In the case of the (4) th aspect, the DO value of the fermentation system is reduced to 9 to 12% for the first time, and thereafter the DO value is maintained at 9 to 12%. The L-homoserine biological components are AspA and AspC paths, and the DO value of the system is 9-12% by dissolved oxygen feedback, so that the cell metabolism can be driven to synthesize homoserine by a more efficient AspC path, and the fermentation yield is improved. And combines the cell density control function of the (2) and (3) to ensure that each stage of the bacterial growth can keep the optimal production state.
As a preferable mode of the above technical scheme of the invention, the recombinant escherichia coli is escherichia coli HS33.
Coli HS33 is disclosed in the documents Multiplex design ofmetabolic network forproduction of L-homoserine in Escherichia coli [ J ]. Applied and environmental microbiology 2020,86 (20) e01477-20, provided by the university of Zhejiang Industrial microorganisms strain collection. It is noted that the above technical scheme of the invention is preferably but not limited to E.coli HS33 genetically engineered bacteria. The recombinant E.coli of the present invention may also be a methionine, lysine and/or threonine deficient strain.
Preferably, the pH of the solution of the present invention is maintained with aqueous ammonia. Preferably, the concentration of ammonia is 45 to 55wt%.
As a preferable mode of the above technical scheme of the invention, the quantitative fed-batch amino acid includes fed-batch threonine, methionine and lysine.
As a preferable mode of the above technical scheme of the invention, the quantitative feeding amount of the amino acid is 10mL.
As a preferable mode of the technical scheme, the DO value is maintained through dissolved oxygen feedback feeding. When the DO value is greater than 10%, feed medium is fed.
Dissolved oxygen feedback control under the condition of hypoxia can drive cell metabolism to synthesize homoserine through a more efficient AspC approach, thereby improving fermentation yield.
As a preferable mode of the above technical scheme of the invention, the composition of the feed medium is: glucose 500g/L, KH 2 PO 4 12.5g/L,(NH 4 ) 2 SO 4 10 g/L, threonine 4g/L, L-methionine 0.5g/L, L-lysine 1g/L, metal ion 2mL/L, betaine 2g/L, VB 12 2 mg/L,VB 1 5mg/L, water as solvent and natural pH.
As a preferable mode of the technical scheme, the fermentation medium comprises the following components: glucose 15g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L, threonine 0.4g/L, methionine 0.125g/L, lysine 0.25g/L, VB 12 2 mg/L,VB 1 5mg/L, betaine 2g/L, defoamer 1mL/L, water as solvent and natural pH.
Compared with the prior art, the invention has the following technical effects:
(1) The fermentation process of L-homoserine provided by the invention can keep the optimal production state at each stage of thallus growth by controlling the pH value, the temperature, the glucose content, the OD600 value and the DO value in a certain range in the fermentation process, and realizes the control of thallus growth in the fermentation process.
(2) The fermentation process of L-homoserine provided by the invention has high yield and good reproducibility.
(3) The fermentation process of L-homoserine provided by the invention can effectively solve the problem of byproduct accumulation in the production process and improve the yield of L-homoserine through low dissolved oxygen, residual sugar and pH control.
Drawings
FIG. 1 is a diagram of the non-optimized fermentation process of E.coli HS33 in comparative example 1 of the present invention;
FIG. 2 is a graph of a 5L tank fermentation process for pulsed feed of amino acids in example 1 of the present invention;
FIG. 3 is a graph of a 5L tank fermentation process under optimal fermentation parameters in example 8 of the present invention.
Detailed Description
The invention is further described below with reference to examples.
The genetically engineered bacteria used in the following examples and comparative examples were HS33 strains constructed and deposited at the university of Zhejiang industry (Multiplex design of metabolic network for production of L-homoserine in Escherichia coli [ J ]. Applied and Environmental microbiology.2020,86 (20) e 01477-20.).
The genotype of the strain is as follows:
ΔmetJΔmetIΔmetBΔthrBΔmetAΔiclRΔptsGΔgalRΔlacI::Trc-rhtATrc-rhtATrc-eamATrc-thrATrc-me tLTrc-glkTrc-gltB。
the fermentation process for producing L-homoserine by using the recombinant escherichia coli mainly aims at solving the problems that in the existing fermentation process for producing L-homoserine by using the recombinant escherichia coli, the growth of thalli is difficult to control and the high yield is difficult to reproduce. For the purpose of understanding the technical scheme of the present invention, comparative example 1 below is compared with examples 1 to 8 of the present invention as a comparative example.
Comparative example 1
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
The composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose 40g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, 1mL/L defoamer, water as solvent, and natural pH.
The feed medium composition is: 500g/L glucose, 12.5g/L KH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, water as solvent, and natural pH.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 28℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 20%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for subsequent detection of L-homoserine content, wherein samples are taken at intervals of 2h in the early stage and 4h in the middle and later stagesAnd (5) sampling once. DO naturally drops to 20% after inoculation, and DO-Stat feedback feed is started. Namely, when DO is more than 20%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Fermentation was ended when DO reached 100%. As shown in FIG. 1, the cells stopped growing and OD after fermentation for 12 hours 600 The sugar consumption speed is slow and the yield is 15.4g/L at the maximum by fluctuation around 13.
Offline parameter determination involved in the above method:
biomass measurement: after a fermentation broth sample was obtained through the sampling port, 2m L was diluted appropriately and placed in a cuvette, and the absorbance (OD) was measured at 600nm using an ultraviolet spectrophotometer 600 )。
Residual sugar detection, principle: the glucose concentration was measured by the 3, 5-dinitrosalicylic acid method (reducing sugar by DNS method). The DNS, namely dinitrosalicylic acid method, utilizes the principle that dinitrosalicylic acid and reducing sugar undergo oxidation-reduction reaction under alkaline condition to generate 3-amino-5-nitrosalicylic acid, the product shows brownish red color under boiling condition, and the color depth and the reducing sugar content are in proportional relation in a certain concentration range, and the reducing sugar content is measured by a colorimetric method. Reagent: 1g/L glucose solution. 3, 5-dinitrosalicylic acid 6.3g of 3, 5-dinitrosalicylic acid was dissolved in 400mL of distilled water, 21g of sodium hydroxide was gradually added, 182g of potassium sodium tartrate tetrahydrate, 5.0g of phenol, 5.0g of anhydrous sodium sulfite were added, and the solution was stirred continuously in a warm water bath until the solution was clear and transparent. Distilled water was used to volume to 1000mL and stored in a brown bottle. Isolated from carbon dioxide. Standing for 5-7 days. Taking five centrifuge tubes with 1.5mL, sequentially adding 0.2mL, 0.4mL, 0.6mL, 0.8mL and 1mL of glucose standard solution into each centrifuge tube, adding water to supplement 1.0mL, and shaking and mixing uniformly to obtain glucose solutions with the concentration of 0.2 g/L, 0.4 g/L, 0.6 g/L, 0.8 g/L and 1.0 g/L. Five 1.5mL centrifuge tubes were each aspirated with 500. Mu.L glucose solution and 500. Mu.L of DNS reagent was added. The mixture was heated in a water bath for 5 minutes, and then 600. Mu.L of the reaction mixture was taken and 2.4mL of distilled water was added. Detection was performed at 540nm in a spectrophotometer. The standard curve is plotted with the measured value at 540nm as ordinate and the glucose concentration as abscissa.
The liquid phase detection method comprises the following steps: the fermentation broth detection time on the tank was chosen every 4 hours. 1mL of the fermentation broth was centrifuged at 12000rpm for 1min at room temperature, and the supernatant was diluted 20-fold and then examined for L-homoserine amino acid production by HPLC. Mobile phase a: pure acetonitrile is filtered by a filter membrane of 0.22 mu m, is subjected to ultrasonic deaeration and is prepared in an on-line way.
Mobile phase B:50mM HAc-NaAc buffer, pure water, acetonitrile, triethylamine (82.8:17:0.2) acetic acid to adjust pH to 4.9. Filtering with 0.22 μm filter membrane, ultrasonic degassing, and preparing. Derivatizing agent I:0.2700g CNBF (3, 5-dinitro-4-chloro-trifluoromethylbenzene) per 10ml acetonitrile; buffer II: pH 9.0H 3 BO 3 -Na 2 B 4 O 7 Buffer solution 0.2mol/L boric acid (H) 3 BO 3 ) With 0.05mol/L borax (Na) 2 B 4 O 7 ) A solution. After being prepared, the materials need to be stored in a dark place. Derivatization method: the sample was diluted to 0.1-2 g/L, 100. Mu.L sample, 300. Mu.L derivatization reagent I, 500. Mu.L buffer II. Placing in a mixing instrument, and reacting at 60 ℃ and 400rpm in a dark place for 1h. After the reaction is finished, the mixture is filtered by a 0.22 mu m syringe type organic filter membrane and is reserved for detection. Detection conditions: chromatographic column: j (J)&K C18-H Column (4.6X250 mm,5 μm); flow rate: 0.80mL/min; column temperature: 30 ℃; sample injection amount: 10.0. Mu.L; detection wavelength: 260nm.
Gradient elution and mobile phase gradient elution times are shown in table 1, for example, as compared to flow.
TABLE 1
Example 1 amino acid pulsed fed-batch fermentation
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
fermentationThe composition of the culture medium is as follows: glucose 40g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, 1mL/L defoamer, water as solvent, and natural pH.
The feed medium composition is: 500g/L glucose, 12.5g/L KH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, water as solvent, and natural pH.
The amino acid feeding bottle is additionally arranged, and the composition of the amino acid feeding bottle is as follows: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 28℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 20%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for subsequent useAnd detecting the content of L-homoserine, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 20% after inoculation, and DO-Stat feedback feed is started. Namely, when DO is more than 20%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity.
Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. When the DO reaches 100%, the fermentation is ended. As a result, as shown in FIG. 2, the yield reached a maximum of 29.8g/L, OD at 96h 600 A maximum of 42.15 is reached at 84 h. The yield was improved by 96.1% compared to comparative example 1.
Example 2 fermentation process initial glucose concentration optimization
When the nutrient concentration such as carbon source in the culture system exceeds a certain critical value, the microorganism can form ion gradient to resist high osmotic pressure and maintain the intracellular environment, which is energy consuming, and the result can obviously inhibit the growth of the thallus, while if the initial glucose concentration is too low, the thallus can be forced to stop growing due to the exhaustion of the carbon source when the thallus is not in the optimal state, so that the selection of the initial carbon source with proper concentration is necessary, and four gradients are set for the initial sugar concentration in the embodiment: 10g/L,15g/L,20g/L and 30g/L.
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose was set to 4 concentration gradients (10 g/L,15g/L,20g/L,30 g/L), (NH 4) 2SO417g/L, yeast Extract 4g/L, KH2PO41 g/L, mgSO40.5 g/L, feSO4.7H2O 0.005g/L, mnSO4.7H2O 0.005g/L, znSO40.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, defoamer 1mL/L, solvent water, pH was natural.
The feed medium composition is: 500g/L glucose, 12.5g/L KH2PO4, 10g/L (NH) 4 ) 2 SO 4 4g/L threonine, 0.5g/L methionine, 1g/L lysine, and 2mL/L metal ion.
Amino acid bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 28℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 20%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 20% after inoculation, and DO-Stat feedback feed is started. Namely, when DO is more than 20%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. When the DO reaches 100%, the fermentation is ended. The final optimal initial sugar concentration is 15g/L, the maximum yield after fermentation to 96h is 40.14g/L, and the yield is improved by 2.6 times compared with the comparative example。
Example 3 fermentation process temperature optimization
The temperature in the fermentation tank has great influence on the activity of microbial cellular enzyme, and the intracellular enzyme activity determines the physiological metabolism activity of cells so as to influence the growth of thalli and the synthesis of products. In this embodiment, the fermentation temperature is gradient optimized, and four temperature gradients are set: 28 ℃,31 ℃,34 ℃ and 37 ℃.
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
The composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose 15g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, 1mL/L defoamer, water as solvent, and natural pH.
The feed medium composition is: 500g/L glucose, 12.5g/LKH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, water as solvent, and natural pH.
Amino acid bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was set at 4 gradients (28 ℃,31 ℃,34 ℃,37 ℃) and the aeration ratio was 2vvm, the rotational speed 300rpm, the pH 6.80, and the dissolved oxygen 20%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 20% after inoculation, and DO-STAT feedback feed is started. Namely, when DO is more than 20%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 Pulse type quantitative feeding of amino acid 10mL each time without obvious change, OD 600 Controlled between 30-50. When the DO reaches 100%, the fermentation is ended. Finally, the optimal fermentation temperature is 31 ℃, the yield reaches the highest value in 72 hours and is 42.56g/L, and the yield is improved by 2.76 times compared with the comparative example; it is notable that the fermentation period is greatly shortened.
Example 4 dissolved oxygen feedback threshold optimization
Coli is a facultative anaerobe that metabolizes and grows in both aerobic and anaerobic environments, but the metabolic pathways are altered, homoserine biosynthesis can also occur through both aerobic and anaerobic pathways, where anaerobic pathways have higher theoretical conversion rates, and it should be noted that too high dissolved oxygen may be detrimental to cell growth, as some thiol-bearing enzymes can be very sensitive to high concentrations of oxygen; at the same time, disturbances in cellular metabolism caused by oxygen starvation may lead to the accumulation of large amounts of byproducts. How to coordinate the two synthetic pathways can be achieved from control of the oxygen concentration of the fermentation process. In order to balance the homoserine biosynthetic pathway, the critical oxygen concentration and the optimal oxygen concentration of the fermentation product need to be examined, so that the fermentation process is kept at the optimal oxygen concentration. In this embodiment, four parameters are set for the dissolved oxygen feedback threshold: 10%,20%,30% and 40%.
The hair medium formulation is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose 15g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, 1mL/L defoamer.
The feed medium composition is: 500g/L glucose, 12.5g/L KH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L methionine, 1g/L lysine, and 2mL/L metal ion.
Amino acid bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 28℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80, and the dissolved oxygen was 4 gradients (10%. 20%,30%, 40%). The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to dissolved oxygen feedback threshold (10%, 20%,30%, 40%) after inoculation, DO-STAT feedback feed is started. Namely, when DO is larger than a set threshold, feeding is started, residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. Fermentation was ended when DO reached 100%. The optimal dissolved oxygen concentration is 10% after screening, the yield is highest after fermentation for 72 hours and reaches 43.43g/L, which is 2.8 times higher than that of the comparative example.
Example 5 betaine concentration optimization
Betaine (N, N-trimethylglycine) is a major compatible solute and also an osmoprotectant, which, due to its specific methylation-related structure, in escherichia coli, is an indispensable role in the growth and production of bacteria. Especially in the field of fermentation, betaine can improve the growth rate and biomass of bacteria in the fermentation process, so that the content of target metabolites is improved, and the osmotic pressure in a liquid culture medium can be increased in the process of producing biological products such as threonine by escherichia coli fermentation, and then the betaine is added into the liquid culture medium by escherichia coli. Meanwhile, betaine has the effect of enhancing the expression of zwf genes related to reducing power and providing reducing power for the synthesis of L-homoserine. In the embodiment, the concentration gradient is set by carrying out gradient optimization on the betaine concentration: 0g/L,1g/L,2g/L and 3g/L.
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose 15g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH2PO41 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, 1mL/L defoamer, water as solvent, and natural pH.
The feed medium composition is: 500g/L glucose, 12.5g/L KH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, betaine set concentration gradient (0 g/L,1g/L,2g/L,3 g/L), water as solvent, and natural pH.
Amino acid bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature is 31 ℃, the aeration ratio is 2vvm, the rotating speed is 300rpm, the pH is 6.80, and the dissolved oxygen is10%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 10% after inoculation, and DO-STAT feedback feed is started. Namely, when DO is more than 10%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. Fermentation was ended when DO reached 100%. The optimal addition amount of the screened betaine is 2g/L, and the yield reaches the highest 41.39g/L when the fermentation is carried out for 60 hours.
EXAMPLE 6VB 12 Concentration optimization
VB 12 Can transfer methyl and transfer one carbon under the action of enzyme, and can provide universal one carbon unit for bioconversion so as to be favorable for synthesizing various cell substances. Further VB 12 The molecules contain cobalt and corrines, and contain Co 2+ Under the condition of high concentration, the activity of methylmalonyl CoA isomerase can be effectively improved, and the tricarboxylic acid cycle efficiency and the oxaloacetic acid yield can be effectively improved by isomerizing the methylmalonyl CoA into succinyl CoA and entering a tricarboxylic acid cycle path. The embodiment is directed to VB 12 Gradient optimization is carried out on the concentration, and the concentration gradient is set: 1mg/L,2mg/L,4mg/L,8mg/L.
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose 15g/L, (NH) 4 ) 2 SO 4 17 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, 2g/L betaine and 1mL/L defoamer.
The composition of the feed medium was: 500g/L glucose, 12.5g/LKH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, metal ion 2mL/L betaine 2g/L VB 12 The concentration gradient (1 mg/L,2mg/L,4mg/L,8 mg/L) is set, the solvent is water, and the pH is natural.
Amino acid bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
Seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 31℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 10%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 10% after inoculation, and DO-STAT feedback feed is started. Namely, when DO is more than 10%, the feeding is started and the residual sugar is controlled The feeding period is regulated according to the residual sugar content and is controlled to be 0.1g/L-5 g/L. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. Fermentation was ended when DO reached 100%. The optimal adding amount of VB12 is 2mg/L, and the yield reaches the highest 40.64g/L when the fermentation is performed for 60 hours.
EXAMPLE 7VB 1 Concentration optimization
The bioactive form of vitamin B1 is thiamine Jiao Linzhi (thiamine pyrophosphate, TPP). High amounts of NADPH are required during homoserine synthesis, and TPP is required as a cofactor for the enzymatic reaction of its biosynthesis; furthermore, TPP is an important cofactor in the pyruvate dehydrogenase complex (PDHC), alpha-ketoglutarate dehydrogenase complex (KGDHC) and Transketolase (TK) reactions of the pentose phosphate pathway. PDHC and KGDHC are important components of the ATP pathway that cells use glucose to produce; TK is a key enzyme for gluconeogenesis. Thiamine has an important role in glucose metabolism as a coenzyme for two key catalytic enzymes in glycolysis. Thus, the concentration of VB1 in this example was gradient optimized, and the concentration gradient was set: 1mg/L;3mg/L;5mg/L;7mg/L.
The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: glucose 15g/L, (NH) 4 ) 2 SO417 g/L,Yeast Extract 4g/L,KH 2 PO 4 1 g/L,MgSO 4 0.5 g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, betaine 2g/L, VB 12 2. 2 mg/L, defoamer 1mL/L.
The composition of the feed medium was: 500g/L glucose, 12.5g/L KH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 ,4gthreonine/L, 0.5g/L L-methionine, 1g/L L-lysine, metal ion 2mL/L, betaine 2g/L, VB 12 2 mg/L,VB 1 The concentration gradient (1 mg/L;3mg/L;5mg/L;7 mg/L) is set, the solvent is water, and the pH is natural.
Amino acid bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
seed liquid culture:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into 10mL test tubes and placed in a constant temperature shaking incubator at 37℃for 10 hours at 180 rpm. Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 31℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 10%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 10% after inoculation, and DO-STAT feedback feed is started. Namely, when DO is more than 10%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. Fermentation was ended when DO reached 100%. VB (VB) 1 The optimal addition amount is 5mg/L, and the yield reaches the highest 45.32g/L when fermentation is carried out for 60 hours.
Example 8 Combined fermentation of optimal factors
Based on the optimal influence factors screened in examples 1 to 7, the present example performs a combination test on the above optimal factors. The formula of the culture medium is as follows:
The first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: 15g/L of glucose, (NH 4) 2SO417 g/L, yeast Extract 4g/L, KH2PO41 g/L, mgSO40.5 g/L, feSO4.7H2O 0.005g/L, mnSO4.7H2O 0.005g/L, znSO40.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, betaine 2g/L, VB122 mg/L, VB15mg/L and defoamer 1mL/L.
The composition of the feed medium was: 500g/L glucose, 12.5g/LKH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, 2g/L betaine, 2mg/LVB12,5mg/LVB1, water as solvent, and natural pH.
Amino acid supplementing bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into test tubes of 10ml in liquid loading amount, placed in a constant temperature shaking incubator at 37℃and cultured for 10 hours at 180 rpm.
Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the second-level seed liquid with the inoculation amount of 10% into a 5L fermentation tank with the liquid loading amount of 2L, wherein the culture conditions are as follows: the temperature was 31℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 10%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 10% after inoculation, and DO-Stat feedback feed is started. Namely, when DO is more than 10%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. Fermentation was ended when DO reached 100%. As a result of fermentation under the optimal conditions of all examples, 75.28g/L of the highest yield was detected at 64h of fermentation, which is 3.82 times that of the comparative example, and the sugar acid conversion rate was 0.45g/g, as shown in FIG. 3.
Example 9 Combined fermentation of optimal factors
The main difference from example 8 is the type of fermenter used for the cultivation, and the other reference example 8.
Based on the optimal influence factors screened in examples 1 to 7, the present example performs a combination test on the above optimal factors. The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: 15g/L of glucose, (NH 4) 2SO417 g/L, yeast Extract 4g/L, KH2PO41 g/L, mgSO40.5 g/L, feSO4.7H2O 0.005g/L, mnSO4.7H2O 0.005g/L, znSO40.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, betaine 2g/L, VB122 mg/L, VB15mg/L and defoamer 1mL/L.
The composition of the feed medium was: 500g/L glucose, 12.5g/LKH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, 2g/L betaine, 2mg/LVB12,5mg/LVB1, water as solvent, and natural pH.
Amino acid supplementing bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into test tubes of 10ml in liquid loading amount, placed in a constant temperature shaking incubator at 37℃and cultured for 10 hours at 180 rpm.
Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the secondary seed liquid with the inoculation amount of 10% into a 10L fermentation tank with the liquid loading amount of 7L, wherein the culture conditions are as follows: the temperature was 31℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 10%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 10% after inoculation, and DO-Stat feedback feed is started. Namely, when DO is more than 10%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Control ofBetween 30-50. Fermentation was ended when DO reached 100%. At the time of fermentation for 66h, 75.21g/L of the highest yield is detected, and the sugar acid conversion rate reaches 0.46g/g.
Example 10 Combined fermentation of optimal factors
The main difference from example 8 is the type of fermenter used for the cultivation, and the other reference example 8.
Based on the optimal influence factors screened in examples 1 to 7, the present example performs a combination test on the above optimal factors. The formula of the culture medium is as follows:
the first seed culture medium consists of: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the secondary seed culture medium is as follows: 10g/L peptone, 5g/L yeast powder and 10g/L NaCl;
the composition of the fermentation medium is: 15g/L of glucose, (NH 4) 2SO417 g/L, yeast Extract 4g/L, KH2PO41 g/L, mgSO40.5 g/L, feSO4.7H2O 0.005g/L, mnSO4.7H2O 0.005g/L, znSO40.005 g/L,0.4g/L threonine, 0.125g/L methionine, 0.25g/L lysine, betaine 2g/L, VB122 mg/L, VB15mg/L and defoamer 1mL/L.
The composition of the feed medium was: 500g/L glucose, 12.5g/LKH 2 PO 4 ,10g/L(NH 4 ) 2 SO 4 4g/L threonine, 0.5g/L L-methionine, 1g/L L-lysine, 2mL/L metal ion, 2g/L betaine, 2mg/LVB12,5mg/LVB1, water as solvent, and natural pH.
Amino acid supplementing bottle: 80g/L threonine, 40g/L methionine and 20g/L lysine.
The L-homoserine fermentation production method comprises the following steps:
the genetic engineering bacteria are activated by inclined plane, bacterial colony is picked up and inoculated into a test tube filled with a primary seed culture medium for culture to be used as primary seed liquid, and the culture conditions of the primary seed liquid are as follows: single colonies were picked into test tubes of 10ml in liquid loading amount, placed in a constant temperature shaking incubator at 37℃and cultured for 10 hours at 180 rpm.
Inoculating the primary seed liquid into a shake flask filled with a secondary seed culture medium to culture the primary seed liquid as a secondary seed liquid, wherein the culture conditions of the secondary seed liquid are as follows: the primary seed solution was inoculated into a 500mL shake flask having a liquid loading amount of 200mL at an inoculum size of 1%, and placed in a constant temperature shaking incubator at 37℃for shaking culture at 180rpm for 10 hours.
Culturing in a fermentation tank:
inoculating the secondary seed liquid with the inoculation amount of 10% into a 10L fermentation tank with the liquid loading amount of 6L, wherein the culture conditions are as follows: the temperature was 31℃and the aeration ratio was 2vvm, the rotational speed was 300rpm, the pH was 6.80 and the dissolved oxygen was 10%. The pH was adjusted to 6.60 with 50% (v/v) of sterilized water and 50% (v/v) of aqueous ammonia in advance (the pH was raised to 6.80 after inoculation, and the pH set point was changed to 6.80). When the fermentation time is about 4 hours, sampling and OD detection are started 600 And residual sugar content, and preserving the fermentation broth for later detection of L-homoserine content, wherein samples are taken at intervals of 2 hours in the early stage and at intervals of 4 hours in the middle and later stages. DO naturally drops to 10% after inoculation, and DO-Stat feedback feed is started. Namely, when DO is more than 10%, the feeding is started, the residual sugar is controlled to be 0.1g/L-5g/L, and the feeding period is adjusted according to the residual sugar residual quantity. Amino acid addition time to OD 1 hr before and after fermentation process 600 The pulse type quantitative feeding amino acid is fed by 10mL each time without obvious change. And OD is taken to 600 Controlled between 30-50. Fermentation was ended when DO reached 100%. At 66h of fermentation, 75.19g/L of the highest yield is detected, and the sugar acid conversion rate reaches 0.44g/g.
The raw materials and equipment used in the invention are common raw materials and equipment in the field unless specified otherwise; the methods used in the present invention are conventional in the art unless otherwise specified.
The foregoing description is only a preferred embodiment of the present invention, and is not intended to limit the present invention, and any simple modification, variation and equivalent transformation of the above embodiment according to the technical substance of the present invention still fall within the scope of the technical solution of the present invention.
Claims (10)
1. A fermentation process for producing L-homoserine by recombinant escherichia coli is characterized in that: taking recombinant escherichia coli for producing L-homoserine as a production strain for fermentation culture, wherein the fermentation process controls the following parameters:
(1) pH and temperature: the pH is maintained at 6.6-7.0, and the temperature is maintained at 30-32 ℃;
(2) Glucose content: the content of glucose is 0.1-5 g/L;
(3)OD 600 value: the bacterial cells enter a stagnation period, pulse type quantitative amino acid feeding is carried out, and OD is carried out 600 The value is in the range of 30-50;
(4) DO value: the DO value of the system is reduced to 9-12% for the first time, and the DO value is maintained at 9-12% after that.
2. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 1, wherein: the recombinant escherichia coli is escherichia coli HS33.
3. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 1, wherein: the pH was maintained with ammonia.
4. A fermentation process for producing L-homoserine by recombinant escherichia coli as claimed in claim 3, wherein: the concentration of the ammonia water is 45-55wt%.
5. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 1, wherein: the quantitative fed-batch amino acid comprises fed-batch threonine, methionine and lysine.
6. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 1 or 5, wherein: the quantitative feeding amount of the amino acid is 10mL in each feeding.
7. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 1, wherein: the DO value is maintained by dissolved oxygen feedback feeding.
8. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 7, wherein: the method for maintaining DO value comprises the following steps: when the DO value is greater than 10%, feed medium is fed.
9. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 8, wherein: the feed medium comprises the following components: glucose 500g/L, KH 2 PO 4 12.5g/L,(NH 4 ) 2 SO 4 10g/L threonine 4g/L, L-methionine 0.5g/L, L-lysine 1g/L, metal ion 2mL/L, betaine 2g/L, VB 12 2mg/L,VB 1 5mg/L, water as solvent and natural pH.
10. The fermentation process for producing L-homoserine by recombinant E.coli according to claim 1, wherein: the fermented culture medium comprises the following components: glucose 15g/L, (NH) 4 ) 2 SO 4 17g/L,Yeast Extract 4g/L,KH 2 PO 4 1g/L,MgSO 4 0.5g/L,FeSO 4 ·7H 2 O 0.005g/L,MnSO 4 ·7H 2 O 0.005g/L,ZnSO 4 0.005g/L, threonine 0.4g/L, methionine 0.125g/L, lysine 0.25g/L, VB 12 2mg/L,VB 1 5mg/L, betaine 2g/L, defoamer 1mL/L, water as solvent and natural pH.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310208931.XA CN116355972A (en) | 2023-03-07 | 2023-03-07 | Fermentation process for producing L-homoserine by recombinant escherichia coli |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310208931.XA CN116355972A (en) | 2023-03-07 | 2023-03-07 | Fermentation process for producing L-homoserine by recombinant escherichia coli |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116355972A true CN116355972A (en) | 2023-06-30 |
Family
ID=86934562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310208931.XA Pending CN116355972A (en) | 2023-03-07 | 2023-03-07 | Fermentation process for producing L-homoserine by recombinant escherichia coli |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116355972A (en) |
-
2023
- 2023-03-07 CN CN202310208931.XA patent/CN116355972A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109609580B (en) | Fermentation medium and fermentation method of riboflavin | |
Zeiger et al. | Model‐based high cell density cultivation of Rhodospirillum rubrum under respiratory dark conditions | |
CN111893146A (en) | Culture medium for improving yield of corynebacterium glutamicum tetrahydropyrimidine and fermentation method | |
CN112481227A (en) | Using vitamin B2Method for increasing FAD-dependent glucose dehydrogenase production | |
CN117230133A (en) | Method for improving pyrroloquinoline quinone titer of methylotrophic bacteria | |
US20230220428A1 (en) | Yeast strain and use thereof and preparation method of ergothioneine | |
CN116333948B (en) | Clostridium aerophilum enrichment medium and preparation method thereof | |
CN112501221A (en) | Method for improving conversion rate of threonine and saccharic acid | |
CN115895976B (en) | Escherichia coli for producing L-tryptophan and application thereof in producing L-tryptophan | |
CN116355972A (en) | Fermentation process for producing L-homoserine by recombinant escherichia coli | |
CN114921502B (en) | Glutaric acid production method for feedback regulation and control of nitrogen source flow based on microorganism physiological parameters | |
CN115637276A (en) | Method for producing tetrahydropyrimidine by using halomonas strain | |
CN114045235B (en) | Method for producing single-cell protein and fermentable sugar by using methanotrophic bacteria | |
CN102399845B (en) | Based on CO in tail gas 2the vitamin B12 fermentative production Controlling Technology of concentration | |
CN116179356A (en) | Method for high-density heterotrophic culture of chlamydomonas reinhardtii and application thereof | |
CN111304138B (en) | Recombinant escherichia coli for producing beta-carotene and construction method and application thereof | |
CN111118090B (en) | Feeding control fermentation method for improving yield of amphotericin B | |
CN115029390A (en) | Method for producing and measuring calcium propionate by using lactobacillus reuteri | |
CN114606275A (en) | Method for producing L-isoleucine through fermentation | |
CN115637233A (en) | Bacterial strain for high yield of dodecanedioic acid and fermentation method | |
CN113862315B (en) | Formula for producing L-phenylalanine by escherichia coli fermentation and application thereof | |
CN110885774A (en) | Method for optimizing glutamic acid fermentation | |
CN117025496B (en) | Escherichia coli fermentation method of recombinant plasmid, culture medium system and application of culture medium system | |
US20060270004A1 (en) | Fermentation processes with low concentrations of carbon-and nitrogen-containing nutrients | |
CN114634902B (en) | Culture medium and culture method for producing psicose epimerase and application of culture medium and culture method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |